Picture of IMBDX logo

461030 IMBDX Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Annual income statement for IMBDX, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Revenue
Total Revenue1571,2302,6254,027
Cost of Revenue
Gross Profit13031.63721,417
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses2,6226,49611,29211,796
Operating Profit-2,465-5,265-8,668-7,769
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-11,067-9,789-10,436-10,416
Provision for Income Taxes
Net Income After Taxes-11,067-9,789-10,436-10,416
Net Income Before Extraordinary Items
Net Income-11,067-9,789-10,436-10,416
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-11,067-9,789-10,436-10,416
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-791-700-746-744
Dividends per Share